Business Wire

The “Centre Hospitalier de la Côte Basque” in France Has Started the Evaluation of the Biolog-id’s C-LOG® Solution

Share

The Centre Hospitalier de la Côte Basque (CHCB) in Bayonne has been using Biolog-id's C-LOG® solution since early April 2019. This solution secures and optimizes the circuit of chemotherapy and immunotherapy, from their preparation all the way to the administration to the patient.

The C-LOG® solution has been used at the CHCB. "During the last HAS audit, a lack of traceability was revealed in the chemotherapy circuit. In order to close this gap, we decided to install the C-LOG® solution which, in addition to securing the administration to the patient's bed, makes it possible to trace the preparation circuit from the pharmacy to the reception in the nurses station," says Dr. Burtin, Pharmacist at CHCB. The solution will be tested for evaluation for 3 months before final adoption.

"The RFID (Radio Frequency Identification) technology is the foundation of our solution. The tag affixed on each preparation contains the product and patient data. This information is updated in real-time and can be consulted throughout the circuit," says Alexandre Guémard, Pharmacist, Product Manager, Biolog-id.

"The automation of information exchanges will facilitate daily actions: inventory management, traceability of returns, transport monitoring," says Dr. Christophe Burtin.

"By ensuring traceability and real-time access to information for healthcare professionals, C-LOG® enhances patient safety, reduces operational costs and improves working conditions," concludes Pierre Parent, President of Biolog-id.

About CHCB

The Centre Hospitalier de la Côte Basque (CHCB) is a Centre Hospital on 3 main sites. Supporting establishment of GHT Navarre-Basque Coast, it gathers more than 300 doctors and 3000 professionals in more than 60 services representing 40 specialties.

About Biolog-id

Biolog-id has developed a patented smart solution for the management and traceability of sensitive health products, based on RFID technology: blood products, plasma for fractionation and chemotherapy. Biolog-id operates in North America, Europe, Middle East, India and Asia Pacific region and has 90 employees worldwide. Biolod-id is owned by its founder, managers and the Xerys Funds.www.biolog-id.com

Contact information

Alexandre Guemard alexandre.guemard@biolog-id.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Lega Serie A and Math&Sport Presented the “Football Virtual Coach”18.11.2019 12:05:00 EETPress release

Lega Serie A and Math&Sport presented today during the “Barça Sports Technology Symposium” in Barcelona the “Football Virtual Coach”, an innovative system that allows technical staff to optimize the performance of their teams through real-time tactical analysis. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191118005201/en/ Starting from the second round of the 2019/2020 Serie A TIM the Lega Serie A will equip all the benches of a tablet with the Football Virtual Coach installed. It has been developed by Math&Sport, an Italian incubated startup (PoliHub – Polytechnic University of Milan). The Virtual Football Coach will analyse data coming from video tracking systems to provide, thanks to Artificial Intelligence, the whole technical staff with the most strategic indications to optimize tactics or countering the opponent’s strategy. The coaches will be able to customize the information based on their strategies. “The Serie A

Cooper Tire Europe Launches Extensive New Rally Tire Range for Tarmac, Classic Tarmac, Gravel and Mud and Snow Applications18.11.2019 12:00:00 EETPress release

Cooper Tire Europe today launched an extensive new rally tire range, providing ultra-high performance and reliability across numerous applications and levels of rallying competition. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191118005135/en/ Cooper Tire Europe today launched an extensive new rally tire range, providing ultra-high performance and reliability across numerous applications and levels of rallying competition. (Photo: Business Wire) Developed and manufactured by Cooper Tire Europe, the new range covers tarmac, classic tarmac, gravel and mud and snow (M+S) applications with the following products: the Cooper Discoverer Tarmac DT1, the Cooper Discoverer Tarmac DT02, the Cooper Rally Classic Tarmac CT01, the Cooper Discoverer Gravel DG1, the Cooper M+S and the Cooper M+S Evo. Within the core range of six tire patterns, 13 different sizes are available – covering 13 to 18 inch rims. The Cooper M+S and Cooper M+S

IDEMIA Launches the Very First Metal Card in Belgium, With Nagelmackers Bank18.11.2019 10:52:00 EETPress release

IDEMIA supplies the very first metal payment card in Belgium, which was launched mid-November for Nagelmackers Bank's Elite and Prestige customers. With this new payment card, Nagelmackers seeks to give its Elite and Prestige customers a top-of-the-range free service. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191117005094/en/ (Photo: Business Wire) The metal card market is booming and is becoming increasingly popular among wealthy clients. According to a recent worldwide poll1, metal cards are the card of choice for 75% of affluent consumers worldwide. This first launch of metal cards in the Belgian market is now set to boost the growth of metal cards in Europe. Is it because the metal card is heavier than other bank cards? Or because of its distinctive sound when put on a table? Whatever the reason, more and more banks use premium metal cards to market high-end services as a distinguishing feature. Designed by IDEMIA w

A 360° Protection Offer of Major Events and Sensitive Sites Presented by Bertin, Exensor and Cnim Air Space at Milipol Paris 201918.11.2019 10:30:00 EETPress release

Leading players in the Defense and Security sector in France & abroad, Bertin Technologies, Exensor, Bertin IT and CNIM Air Space (CNIM Group companies) will be exhibiting at the GICAT Pavilion to present their complementary operational solutions dedicated to the protection of people and the surveillance of the interests of States and communities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191117005033/en/ A 360° protection offer of major events and sensitive sites presented by Bertin, Exensor and Cnim Air Space at Milipol Paris 2019. (Graphic: Bertin) This event will be the opportunity to highlight our news: - New contract: Exensor & Siltec announce the signature of a major contract with the Polish Ministry of Defense to supply 116 Unattended Ground Sensor (UGS) systems - CNIM Air Space, formerly Airstar Aerospace, joined the CNIM Group in March 2019. Thanks to its experience gained in projects designed for the benefit

Bempedoic Acid Lowers LDL-Cholesterol without Adversely Impacting Glycaemic Control in Pooled Analyses of Phase 3 Trials Presented at the American Heart Association 2019 Scientific Sessions18.11.2019 10:00:00 EETPress release

Daiichi Sankyo Europe GmbH (hereafter, ‘Daiichi Sankyo’) today announced the results of two pooled analyses from four Phase 3 clinical trials of bempedoic acid which were presented at the American Heart Association (AHA) Scientific Sessions in Philadelphia. Bempedoic acid is currently undergoing review for marketing authorisation by the European Medicines Agency (EMA) and by the United States Food and Drug Administration (FDA). One presentation highlighted that bempedoic acid reduced haemoglobin A1c (HbA1c) by 0.19% versus placebo in patients with diabetes at 12 weeks.2 HbA1c is a standard measure of glycaemic control used in diabetes management. The analysis also showed that patients on bempedoic acid had fewer instances of new-onset diabetes as well as hyperglycaemia than those on placebo.2 The pooled analysis suggests that bempedoic acid does not have an adverse impact on glycaemic control in patients with and without diabetes when added to a stable background of lipid lowering ther

DaraPay Announces Strategic Partnership with Chinese Tech Giant- Alipay18.11.2019 06:26:00 EETPress release

DaraPay, the leading mobile E-wallet and payment service providers, today announces its partnership with Alipay, world’s leading payment and lifestyle platform operated by Ant Financial. With this partnership, Chinese tourists can scan and pay with their Alipay app at all DaraPay merchants with more than 3,000 outlets in Phnom Penh, Kandal, Kampong Cham, Siem Reap and Battambang province. Alipay serves over 1.2 billion users together with its regional partners and is the preferred payment method of Chinese tourists1. Through this strategic partnership, the two partners are looking to integrate their respective systems with one another and offer the market a flexible, on-demand digital payment solution through which Chinese tourists can conveniently use during their visit to Cambodia. With the system now in place, Alipay users are no longer required to withdraw cash or perform cross-app money transfer to make payments across the Kingdom. They can simply complete their purchases by scann

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom